Description
A potent LRRK2 inhibitor (IC50 = 4.76 nM for the human recombinant kinase); inhibits LRRK2G2019S (IC50 = 6.87 nM); reduces LRRK2G2019S-induced cell injury in rat primary cortical neurons
Formal name: N-[2-[[5-fluoro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-methanesulfonamide
Synonyms:
Molecular weight: 488.5
CAS: 1191911-26-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Other Serine/Threonine Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cell Biology|Cell Signaling||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease